KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Times Interest Earned (2018 - 2019)

Acadia Pharmaceuticals (ACAD) has 2 years of Times Interest Earned data on record, last reported at -$4757.6 in Q2 2019.

  • For Q2 2019, Times Interest Earned changed N/A year-over-year to -$4757.6; the TTM value through Mar 2020 reached -$20702.2, down 44782.08%, while the annual FY2018 figure was -$27.84, N/A changed from the prior year.
  • Times Interest Earned reached -$4757.6 in Q2 2019 per ACAD's latest filing, down from -$382.68 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$35.62 in Q3 2018 and bottomed at -$4757.6 in Q2 2019.